STING1 and cervical cancer: It has been demonstrated that activation of STING with ADUS100 promotes the expression of IFN β and IL - 6, increases the number of CD8 + T cells and CD103 + dendritic cells, and inhibits the ex vivo and in vivo growth of cervical cancer cells (110).